The AI Frontier: A Founder's Vision for Cancer's Future

What if AI could drastically accelerate the development of cancer treatments? This is the challenge French startup Orakl Oncology is tackling head-on. In this session, discover how the company is reshaping drug development by combining real-world patient data with cutting-edge biology to create an AI-powered platform. Join the founder, in conversation with a key investor, as they reveal how this approach is redefining the future of oncology, improving clinical trial success, and driving the next generation of cancer therapies.